Sonoma Pharmaceuticals, Inc. SNOA Q3 2025 earnings
Reported November 4, 2025 · Before market open
Revenue estimate$4.3M
EPS estimate-$0.31
Next report
Aug 6, 2026 (In 3 weeks)Revenue estimate$5.0M
EPS estimate-$0.30
Versus estimates
Revenue
Diluted EPS
Ask the moment Sonoma Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Sonoma Pharmaceuticals, Inc. report Q3 2025 earnings?
- Sonoma Pharmaceuticals, Inc. (SNOA) reported Q3 2025 earnings on November 4, 2025 before market open.
- What were Sonoma Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
- Sonoma Pharmaceuticals, Inc. reported revenue of $5.6M and diluted EPS of $-0.13 for Q3 2025.
- Did Sonoma Pharmaceuticals, Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $4.3M by $1.3M. EPS beat the consensus estimate of $-0.31 by $0.18.
- How did Sonoma Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 56.6% from $3.6M a year earlier and diluted EPS grew 78.0% from $-0.59.
- Where can I find Sonoma Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001683168-25-007938) directly on SEC EDGAR. The filing index links above go to sec.gov.